“........In the past only 100,000 people per year have tried Actipatch, but now that we’re starting to expand, reaching 100,000’s per quarter and soon millions per quarter, those newbies trying this for the first time have to wonder if it’s too late to invest in this new technology. When they do and find the price is still an embryo, I see lots of new investors moving in.
We know the product works really well, and the new people seeking pain relief should have their “WOW experience” using Actipatch. Exponential growth is already in motion.”
Your common sense is more powerful than most can imagine 2Relax. Allow me to use your numbers and logic....
“Soon millions per quarter”, let’s say 3?
That’s 12 Million devices annually X $30 = $360 Million in annual sales. Any way one analyses the projection, the market cap becomes substantial.
We know from human trial data accepted by FDA that ActiPatch is efficacious in >77% of those who try it.
ActiPatch is drug-free and totally safe, zero side-effects, ever. ActiPatch is battery powered, economical at 4 cents per hour, and it is a consumable! So, how many will buy how many per year? Depends on their pain and usage, 2, 4, 8? It is estimated chronic pain sufferers in the UK will go through at least 8 per annum. In my opinion, that may prove light when people double up......we have so many ‘two ofs’ hands, wrists, arms, shoulders, knees, etc.
Now calculate market cap and ask the simple question - should BIEL already be north of 5 cents? Just because it trades on the Pink Sheets, where Banks, brokers, institutions and the world say only fools abound, at what point will people say to themselves, “BIEL is different, it trades on the Pinks because the guy who dragged the company through regulatory swamps in the USA & UK did so on a shoestring budget and to save money...” and buy stock, that, incidentally, is very closely held?
You tell me when, because that could be the wake-up call of all time.....
News 
Market Data 
Discover 
